SCHRODER INVESTMENT MANAGEMENT GROUP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1086619
London, X0
Position in TEVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$131,813,250
-$99,979,826 QoQ
Shares Held
4,376,270
-41.1% QoQ
Ownership
0.376%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $254,809,935 across 13 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (51.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
4,376,270 | $131,813,250 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
45,631 | $27,058,269 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
1,006,532 | $24,086,309 | |
| 4 | HCM |
HUTCHMED (China) Ltd
|
1,477,494 | $22,103,310 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
732,766 | $15,212,221 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
71,711 | $9,447,207 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
176,076 | $9,101,368 | |
| 8 | ZTS |
Zoetis Inc.
|
31,553 | $3,729,878 |
All Filings in TEVA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $131,813,250 | 4,376,270 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $231,793,076 | 7,426,885 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,543,965 | 2,056,632 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $34,451,319 | 2,055,568 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $34,651,695 | 2,254,502 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $49,144,483 | 2,229,786 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $16,392,974 | 909,710 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,693,787 | 1,027,310 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,045,213 | 853,665 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,343,229 | 607,589 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $339,063 | 37,178 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $180,759 | 22,399 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,974,017 | 395,481 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,660,570 | 709,326 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,629,644 | 702,827 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,063,826 | 725,239 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,160,372 | 723,270 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $359,390 | 31,143 | Shares | Sole | 2021-05-28 | |
| 2020-03-31 | $13,362 | 1,488 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||